Proportioning of the albumin modified by ischemia (IMA) within the framework of programmed angioplasties;Dosage de l'albumine modifiée par l'ischémie (IMA) dans le cadre d'angioplasties programmées

Immuno-Analyse et Biologie Specialisee

Volumn 20, Issue 4, 2005, Pages 221-227

  Lagabrielle, J F ^a   Delarche, N ^a   Adamou, T H ^a   Fabre, E ^a  

^a CENTRE HOSPITALIER DE PAU   (France)

Author keywords

Angioplasty; IMA; Myocardial ischemia

Indexed keywords

ALBUMIN;

ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE ISCHEMIA; HEMOCONCENTRATION; HUMAN; ISCHEMIC HEART DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; SERUM; TIME;

EID: 23944432885     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2005.05.005     Document Type: Article

References (30)

1. F.S. Apple, H.E. Quist, A.P. Otto, W.E. Mathews, and M.M. Murakami "Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the cobalt-inding test after a Marathon race" Clin. Chem. 48 2002 1097 1100
2. S. Baldus, C. Heeschen, T. Meinertz, A.M. Zeiher, J.P. Eiserich, and T. Mùnzel "Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes" Circulation 2003 1440 1445 (23 sept.)
3. 2+ binding amino-acid residues of the N-terminus of human albumin" Eur. J. Biochem. 268 2001 42 47
4. D. Bar-Or, J.V. Winkler, K. VanBenthuysen, L. Harris, E. Lau, and F.W. Hetzel "Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I" Am. Heart J. 141 2001 985 991
5. S. Blankenberg, H.J. Tupprecht, C. Bickel, M. Torzewski, G. Hafner, and L. Tiret "Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease" N. Engl. J. Med. 349 2003 1605 1613
6. D. Borderie, Y. Allanore, C. Meune, J.Y. Devaux, O.G. Ekindjian, and A. Kahan "High Ischemia-Modified Albumin concentration reflects oxidative stress but not myocardial involvement in Systemic Sclerosis" Clin. Chem. 50 2004 2190 2193
7. M.L. Brennan, M.S. Penn, F. Van Lente, V. Nambi, M.H. Shishehbor, and R.J. Aviles Prognostic value of myeloperoxidase in patients with chest pain N. Engl. J. Med. 349 2003 1595 1604
8. M. Chevion, Y. Jiang, R. Har-El, E. Berenshtein, G. Uretzky, and N. Kritossky Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury Proc. Natl. Acad. Sci. USA 90 1993 1102 1106
9. C. De Filippi, S. Yoon, C. Bouds, L. Romar, A. Ro, and W. Herzog "Early detection of myocardial ischemia by a novel blood-based biomarker: the kinetics of Ischemia-Modified Albumin". Presented at the American congress of cardiology Mars 2003
10. I.P. Garrido, D. Roy, R. Calvino, J.M. Vazquez-Rodriguez, G. Aldama, and J. Cosin-Sales Comparison of Ischemia-Modified Albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals Am. J. Cardiol. 93 2004 88 90
11. S. Gidenne, F. Ceppa, E. Fontan, F. Perrier, and P. Burnat "Analytical performance of the albumin cobalt binding (ACB Test) on the Cobas Mira Plus analyser" Clin. Chem. Lab. Med. 42 2004 455 461
12. R.L. Jesse, and P. Crosby "The role for a biochemical marker of ischemia in the management of patients with acute coronary syndromes". Presented at the World congress of cardiology (Sydney) May 2002
13. e colloque CORATA Paris Octobre 2004
14. R.L. Levine "Ischemia: from acidosis to oxidation" FASEB J. 7 1993 1242 1246
15. G. Marx, and M. Chevion "Site-specific modification of albumin by free radicals" Biochem. J. 236 1985 397 400
16. I.F. Purcell, A. Gomma, K. Bainbridge, D. Gaze, K. Fox, and P.O. Collinson "Investigation of a novel marker for ischaemia during percutaneous coronary intervention and its relationship with restenosis and troponin release" Eur. Heart J. 23 Suppl. 2002 469 (Abstr)
17. J. Quiles, D. Roy, D. Gaze, I.P. Garrido, P. Avanzas, M. Sinha, and J.C. Kaski "Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia Am. J. Cardiol. 92 2003 322 324
18. D. Roy, J. Quiles, M. Sinha, G. Aldama, D. Gaze, and J. Kaski "Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation" Am. J. Cardiol. 93 2004 366 368
19. D. Roy, J. Quiles, M. Sinha, D. Floros, D. Gaze, and P. Collinson "Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin" Am. J. Cardiol. 94 2004 234 236
20. D. Roy, J. Quiles, R. Sharma, M. Sinha, P. Avanzas, and D. Gaze "Ischemia-Modified Albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia" Clin. Chem. 50 2004 1656 1660
21. D. Roy, J. Quiles, G. Aldama, M. Sinha, P. Avanzas, and R. Arroyo-Espliguero "Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T" Int. J. Cardiol. 97 2004 297 301
22. M.S. Sabatine, D.A. Morrow, J.A. De Lemos, T. Omland, M.Y. Desai, and M. Tanasijevic "Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia" J. Am. Coll. Cardiol. 10 2004 1988 1995
23. A. Sacchetti "Ischemia modified albumin: a new biochemical marker of myocardial ischemia" Emerg. Med. J. 21 2004 3 4
24. M. Sinha, D. Gaze, P. Collinson, and J.C. Kaski "Ischemia modified albumin (IMA): a marker of ischaemia in patients presenting to the emergency department with chest pain". Presented at the European society of cardiology meeting. Berlin 2002
25. M. Sinha, D. Gaze, P. Collinson, and J.C. Kaski "The role of ischemia modified albumin (IMA) a new biochemical marker of myocardial ischaemia in the early diagnosis of acute coronary syndromes" Circulation 106 19 2002 (II-455)
26. M. Sinha, D. Gaze, J.R. Tippins, P. Collinson, and J.C. Kaski "Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention" Circulation 2003 2403 2405 (20 May)
27. M. Sinha, D. Roy, D.C. Gaze, P.O. Collinson, and J.C. Kasli "Role of the ischemia modified albumin, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes" Emerg. Med. J. 21 2004 29 34
28. M.F. Walter, R.F. Jacob, J. Barrett, M.M. Ghadanfar, G.M. Preston, J. Buch, and R.P. Mason "Serum levels of thiobarbituric acid reactive substances predict cardiovascular events in patients with stable coronary artery disease" J. Am. Coll. Cardiol. 44 2004 1996 2002
29. H. Wayment, C. Grande, C. Garlock, and G.J. Fagan "Analytical performance of the ACB test for ischemia on the Cobas MIRA and Hitachi 911" Clin. Chem. 48 6 2002 A100
30. A.H. Wu "The ischemia -modified albumin biomarker for myocardial ischemia" Med. Lab. Obs. 35 2003 36 38